Reference for CAPOX. Search for CAPOX

AI searches containing CAPOX

CAPOX

CAPOX

Chemotherapy regimen

CAPOX (also called XELOX) is a chemotherapy regimen consisting of capecitabine (trade name Xeloda) combined with oxaliplatin. Xelox regime operates in

CAPOX

Zolbetuximab

Monoclonal antibody

NCT03653507 for "A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN)

Zolbetuximab

Colorectal cancer

Cancer of the colon or rectum

being an intravenous medicine. Some specific regimens used for CRC are CAPOX, FOLFOX, FOLFOXIRI, and FOLFIRI. Antiangiogenic drugs such as bevacizumab

Colorectal cancer

Colorectal_cancer

Oxaliplatin

Pharmaceutical drug

combination known as FOLFOX or along with capecitabine in a combination known as CAPOX or XELOX. It also has uses in pancreatic cancer and stomach cancer or esophageal

Oxaliplatin

Uğur Şahin

German oncologist and immunologist (born 1965)

26 October 2020 "A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN)

Uğur Şahin

Uğur_Şahin

BOLD-100

Experimental cancer drug

of BOLD-100 in combination with FOLFOX in patients with advanced mCRC previously treated with FOLFOX/CAPOX—Efficacy and safety analysis". AACR. 2024.

BOLD-100

Encorafenib

Chemical compound

(encorafenib+cetuximab+mFOLFOX6 arm); or mFOLFOX6, FOLFOXIRI (both every 2 weeks) or CAPOX (every 3 weeks)-each with or without bevacizumab (control arm). The trial

Encorafenib

Chemotherapy regimen

Regimen commonly used in chemotherapy

cyclophosphamide, doxorubicin (Adriamycin), fluorouracil (5-FU) breast cancer CAPOX or XELOX capecitabine and oxaliplatin colorectal cancer CAV cyclophosphamide

Chemotherapy regimen

Chemotherapy_regimen

Functional drug sensitivity testing

Test to guide treatment for cancer

agents (5-FU, oxaliplatin, irinotecan, individually or in combinations (CAPOX, FOLFOX, FOLFIRI, FOLFOXIRI), as well as to other cytotoxic substances.

Functional drug sensitivity testing

Functional_drug_sensitivity_testing

Ji Jiafu

Chinese oncologist (born 1959)

with advanced gastric cancer, the adjuvant capecitabine and oxaliplatin (CAPOX) chemotherapy increased the 3-year disease-free survival rate after gastrectomy

Ji Jiafu